Cough Management in Patients with Codeine and Guaifenesin Allergies

Primary Recommendation: Dextromethorphan Liquid

The British Thoracic Society recommends dextromethorphan as the preferred pharmacological option due to its superior efficacy and better safety profile compared to codeine and other opioid antitussives 1
Dextromethorphan is a non-sedating opiate that effectively suppresses the cough reflex centrally, with maximum suppression occurring at 60 mg 1, 2
A clear dose-response relationship exists, with higher doses (up to 60 mg) providing optimal cough suppression 1, 2

First-generation antihistamines with sedative properties can suppress cough and are particularly useful for nocturnal cough 1, 2
Diphenhydramine liquid is effective for cough suppression, especially when sleep disruption is a concern 3
Ipratropium bromide is the only inhaled anticholinergic agent recommended for cough suppression due to upper respiratory infection or chronic bronchitis 3, 2

Simple home remedies like honey and lemon are recommended as first-line treatment and are often as effective as pharmacological treatments 1, 2

Codeine and pholcodine have no greater efficacy than dextromethorphan but carry significant adverse side effect profiles 1, 2
Guaifenesin is ineffective for cough suppression and is contraindicated due to the patient's allergy 3

Start with honey and lemon mixture for benign viral cough 1, 2
If pharmacological treatment is needed, prescribe dextromethorphan liquid (verify no guaifenesin in formulation) at appropriate doses up to 60 mg for maximum effect 1, 2
For nighttime cough disrupting sleep, consider first-generation antihistamine liquid (e.g., diphenhydramine) 1, 2
For cough associated with URI or bronchitis not responding to oral agents, consider ipratropium bromide nebulizer 3, 2

Failing to verify that combination cough preparations do not contain guaifenesin, which would trigger the patient's allergy 2
Prescribing codeine-containing products, which offer no advantage over dextromethorphan and have more adverse effects 1, 2
Using subtherapeutic doses of dextromethorphan (less than 60 mg may be inadequate for severe cough) 1, 2